These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 35218003)

  • 1. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.
    Sanz Codina M; Zeitlinger M
    Clin Pharmacokinet; 2022 May; 61(5):593-617. PubMed ID: 35218003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and prognostic evaluation of endothelial cell-specific molecule1, von Willebrand factor, and a disintegrin-like and metalloprotease with thrombospondin type 1 motif for sepsis in the emergency department: An observational study.
    Zhang Q; Li CS
    Exp Ther Med; 2019 Jun; 17(6):4527-4535. PubMed ID: 31086585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
    Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
    Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients.
    Roderburg C; Koch A; Tacke F; Nieuwenhuijsen L; Bruensing J; Vargas Cardenas D; Kreggenwinkel K; Vucur M; Koppe C; Jungebluth P; Seikrit C; Luedde M; Trautwein C; Luedde T
    J Crit Care; 2013 Oct; 28(5):882.e1-11. PubMed ID: 23337484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of sampling from a peripheral venous catheter compared to repeated venepunctures on markers of coagulation, inflammation, and endothelial function.
    Espenhain Landgrebe L; Schlosser Mose L; Palarasah Y; Sidelmann JJ; Bladbjerg EM
    Scand J Clin Lab Invest; 2019 Dec; 79(8):584-589. PubMed ID: 31631713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antiplatelet agents in sepsis: a glimpse into the future.
    Akinosoglou K; Alexopoulos D
    Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelial cell injury with inflammatory cytokine and coagulation in patients with sepsis.
    Ding H; Cao XY; Ma XG; Zhou WJ
    World J Emerg Med; 2013; 4(4):285-9. PubMed ID: 25215134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure.
    Martin K; Borgel D; Lerolle N; Feys HB; Trinquart L; Vanhoorelbeke K; Deckmyn H; Legendre P; Diehl JL; Baruch D
    Crit Care Med; 2007 Oct; 35(10):2375-82. PubMed ID: 17944029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated biomarkers of endothelial dysfunction/activation at ICU admission are associated with sepsis development.
    Vassiliou AG; Mastora Z; Orfanos SE; Jahaj E; Maniatis NA; Koutsoukou A; Armaganidis A; Kotanidou A
    Cytokine; 2014 Oct; 69(2):240-7. PubMed ID: 25016133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil cell surface receptors and their intracellular signal transduction pathways.
    Futosi K; Fodor S; Mócsai A
    Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients].
    Chen Y; Huang X; Kong G; Liu X; Tian H; Lyu B; Ning F; Wang T; Hao D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):933-937. PubMed ID: 32912405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.
    Shapiro NI; Schuetz P; Yano K; Sorasaki M; Parikh SM; Jones AE; Trzeciak S; Ngo L; Aird WC
    Crit Care; 2010; 14(5):R182. PubMed ID: 20942957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.
    Whitney JE; Zhang B; Koterba N; Chen F; Bush J; Graham K; Lacey SF; Melenhorst JJ; Teachey DT; Mensinger JL; Yehya N; Weiss SL
    Crit Care Med; 2020 Mar; 48(3):344-352. PubMed ID: 32058372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
    Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
    Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of endothelial cell activation in early sepsis.
    Skibsted S; Jones AE; Puskarich MA; Arnold R; Sherwin R; Trzeciak S; Schuetz P; Aird WC; Shapiro NI
    Shock; 2013 May; 39(5):427-32. PubMed ID: 23524845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy.
    Kanji S; Roger C; Taccone FS; Muller L
    Pharmacotherapy; 2023 Nov; 43(11):1194-1205. PubMed ID: 37491976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.